Rebecca Schaub
Pediatric Endocrinology · Oklahoma City, OKNPI 1609042209
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.1% of the total across 151 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 13.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,285 and has fallen 71.5% since, to $367 in 2025.
Across 151 payments — averaging $18.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$368
- Novo Nordisk$281
- Lilly USA, LLC$269
- AbbVie$265
- Tolmar Pharmaceuticals, Inc.$189
- Insulet Corporation$182
- plus $1K from 25 others
What the payments were for
- Food & beverage$2,76498%
- Education$522%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 10 | $368 |
| Novo Nordisk | 17 | $281 |
| Lilly USA, LLC | 21 | $269 |
| AbbVie | 14 | $265 |
| Tolmar Pharmaceuticals, Inc. | 11 | $189 |
| Insulet Corporation | 11 | $182 |
| Xeris Pharmaceuticals, Inc. | 8 | $156 |
| Sanofi-aventis U.S. LLC | 1 | $117 |
| Vistapharm, Inc. | 6 | $113 |
| Medtronic(2 entities) | 7 | $101 |
| Arbor Pharmaceuticals, Inc. | 5 | $97 |
| Zealand Pharma US, Inc. | 4 | $65 |
| Abbott | 3 | $63 |
| BD | 3 | $63 |
| Ultragenyx Pharmaceutical Inc. | 3 | $61 |
| Merck | 4 | $58 |
| Amgen | 4 | $54 |
| Endo Pharmaceuticals Inc. | 3 | $38 |
| Lifescan, Inc. | 2 | $35 |
| Mannkind Corporation | 1 | $34 |
| Pfizer | 2 | $33 |
| Rhythm Pharmaceuticals, Inc. | 1 | $25 |
| Organogenesis Inc. | 2 | $24 |
| Corcept Therapeutics | 1 | $20 |
| Eton Pharmaceuticals, Inc. | 1 | $18 |
| Nevro Corp. | 1 | $16 |
| Bayer | 1 | $16 |
| Dexcom, Inc. | 1 | $15 |
| Companion Medical, Inc. | 1 | $15 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| IBSA Pharma Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TZIELD$117
How this compares
Too few pediatric endocrinology providers in Oklahomato place this figure against a meaningful peer group, so we don't.
Other pediatric endocrinology in Oklahoma City
- Steven ChernausekOklahoma City$41K
- Ankur RughaniOklahoma City$20K
- Kenneth CopelandOklahoma City$15K
- David SparlingOklahoma City$1K
- Paul DasariOklahoma City$1K
- Minu GeorgeOklahoma City$511
- Maha YousifOklahoma City$309
- Jonathan MeyerOklahoma City$216
- Piers BlackettOklahoma City$124
- Shelly MercerTulsa$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.